Literature DB >> 9741397

The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus.

D H Gilden1, J L Bennett, B K Kleinschmidt-DeMasters, D D Song, A S Yee, I Steiner.   

Abstract

We studied four patients with subacute to chronic varicella zoster virus (VZV) infection of the central nervous system (CNS). VZV infection was verified by detecting antibody to VZV in the cerebrospinal fluid (CSF). VZV caused myelitis in two patients and encephalitis in two patients. In one of the patients with VZV encephalitis, in addition to VZV IgM antibody, VZV DNA was found in the CSF. Among the four patients with VZV infection of the CNS, CSF antibody to VZV was the crucial diagnostic laboratory test which corroborated the clinical features, and indicated that VZV caused neurologic disease. In addition to looking for amplifiable VZV DNA in the CSF of patients with neurologic disease whose clinical and radiologic features suggest VZV infection, we also recommend a search for CSF antibody to VZV, particularly in patients with intervals of weeks to months between zoster and the onset of neurologic disease, or in those patients without rash in whom the tempo of illness is unknown.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741397     DOI: 10.1016/s0022-510x(98)00153-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

Review 1.  Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature.

Authors:  Aaron Haug; Ravi Mahalingam; Randall J Cohrs; D Scott Schmid; John R Corboy; Don Gilden
Journal:  J Neurol Sci       Date:  2010-02-19       Impact factor: 3.181

Review 2.  Neurological disease produced by varicella zoster virus reactivation without rash.

Authors:  Don Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid.

Authors:  Iñigo Corral; Carmen Quereda; Antonio Antela; Vicente Pintado; José Luis Casado; Pilar Martín-Dávila; Enrique Navas; Santiago Moreno
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

4.  Myelopathy after zoster virus infection in immunocompetent patients: A case series.

Authors:  Nouha Farhat; Sawsan Daoud; Olfa Hdiji; Salma Sakka; Mariem Damak; Chokri Mhiri
Journal:  J Spinal Cord Med       Date:  2019-04-23       Impact factor: 1.985

5.  Patients with an acute zonal occult outer retinopathy-like illness rapidly improve with valacyclovir treatment.

Authors:  Vinit B Mahajan; Edwin M Stone
Journal:  Am J Ophthalmol       Date:  2010-08-05       Impact factor: 5.258

6.  Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system.

Authors:  S M Gregoire; V van Pesch; S Goffette; A Peeters; C J M Sindic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-25       Impact factor: 10.154

Review 7.  Molecular methods for diagnosis of viral encephalitis.

Authors:  Roberta L Debiasi; Kenneth L Tyler
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 8.  The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

Authors:  M A Nagel; R J Cohrs; R Mahalingam; M C Wellish; B Forghani; A Schiller; J E Safdieh; E Kamenkovich; L W Ostrow; M Levy; B Greenberg; A N Russman; I Katzan; C J Gardner; M Häusler; R Nau; T Saraya; H Wada; H Goto; M de Martino; M Ueno; W D Brown; C Terborg; D H Gilden
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

Review 9.  Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Authors:  Niklaus H Mueller; Donald H Gilden; Randall J Cohrs; Ravi Mahalingam; Maria A Nagel
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

Review 10.  Diagnostic Testing of Neurologic Infections.

Authors:  Prashanth S Ramachandran; Michael R Wilson
Journal:  Neurol Clin       Date:  2018-11       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.